Muhammad Riazuddin

Muhammad Riazuddin

Auto-generated profile, based on publicly available information

Muhammad Riazuddin

Department of Internal Medicine, King Faisal Specialist Hospital & Research Centre, Alfaisal University Centre, Riyadh, Saudi Arabia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in AME Case Reports
Verified
Journal Article
Open access
PDF file
MAMansour Ibrahim Alrasheed
Mansour Ibrahim Alrasheed
RAReem Khalid Almanea
Reem Khalid Almanea
BHBashayr Mohammed Hijaz
Bashayr Mohammed Hijaz
MRMuhammad Riazuddin
Muhammad Riazuddin
Background: Hyponatremia, a prevalent electrolyte imbalance with varying degrees of severity, can lead to mild to severe complications. Trimethoprim-sulfamethoxazole (TMP-SMX) and spironolactone are two frequently administered medications; regrettably, most healthcare professionals are not aware that these medications might cause hyponatremia. Concurrently, the two drugs have a high chance of medication interactions that raise the risk of hyponatremia, hyperkalemia, and death overall. TMP-SMX is implicated in causing hyponatremia through diverse mechanisms, such as inhibiting the renal tubular epithelial enzyme carbonic anhydrase. Structurally akin to the potassium-sparing diuretic amiloride, TMP-SMX is linked to hyperkalemia and hyponatremia by obstructing epithelial sodium channels in the distal nephron. Moreover, TMP-SMX may enhance antidiuretic hormone (ADH) release, exacerbating the imbalance. Case Description: This is a case of a 76-year-old man with a medical history including hypertension, type II diabetes, coronary artery disease, and dyslipidemia. This case highlights an elderly patient treated with TMP-SMX for a soft tissue wound infection, which resulted in severe hyponatremia. Conclusions: Timely identification and careful monitoring of TMP-SMX-induced hyponatremia enabled the correction of sodium levels without severe complications. Thus, this report underscores the importance of vigilant monitoring and prompt identification of hyponatremia in patients undergoing TMP-SMX treatment. Further research is warranted due to limited data on the precise mechanisms of TMP-SMX-induced hyponatremia.

5 October 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MRMuhammad Riazuddin
Muhammad Riazuddin
NFNoha Ibrahim Farouk
Noha Ibrahim Farouk
SASaad Salman Ali
Saad Salman Ali
MBMuhammad Imran Butt
Muhammad Imran Butt
Tarek ArabiTarek Arabi
Tarek Arabi
KAKhaled M AlKattan
Khaled M AlKattan
Introduction: Lymphangiomatosis is a rare abnormal proliferation of lymphatic vessels involving multiple organs like the brain, lung, heart, spleen, liver, and bones. Lymphangiomas constitute 5.6% of all benign tumors in infancy and adulthood. Case presentation: We report a case of a young lady who presented with constitutional symptoms and progressive dyspnea. Her medical history is significant for muco-cutaneous albinism, diffuse hemangiomas of the bone and viscera, and consumptive coagulopathy status post-splenectomy. After initial investigations, she was found to have right-sided pleural effusion. Pleural fluid analysis indicated chylothorax. She had multiple drainages of the pleural fluid done, and afterward, ligation of the right thoracic duct was performed with a trial of sirolimus, which improved her chylothorax. Clinical discussion: Several case reports have reported positive outcomes with sirolimus in the treatment of lymphangiomatosis. However, larger controlled studies are needed to confirm these findings. Conclusion: Sirolimus is promising as a medical treatment for diffuse pulmonary lymphangiomatosis.

26 December 2020 in Galen Medical Journal
Verified
Journal Article
Open access
PDF file
MRMuhammad Riazuddin
Muhammad Riazuddin
MMMohamed Ahmed Mpharm
Mohamed Ahmed Mpharm
MBMuhammad Imran Butt
Muhammad Imran Butt
MAMuhammad Abufarhaneh
Muhammad Abufarhaneh
SKShahid Masud Khan
Shahid Masud Khan
AAAbdulaziz Alrashed
Abdulaziz Alrashed
Background: Atrial fibrillation (AF) and Venous Thromboembolism (VTE) are significant causes of morbidity and mortality. Direct oral anticoagulants (DOACs) are as effective as vitamin K antagonists (VKAs) with a propensity to cause less major bleeding. This study aimed to assess the safety and effectiveness of rivaroxaban in routine clinical practice in a large tertiary referral center in Saudi Arabia. Methods and Materials: In this study, patients who received rivaroxaban at a tertiary referral hospital were included in this study. All adverse events were recorded, including major bleeding, non-major bleeding events, symptomatic thromboembolic events (deep vein thrombosis, pulmonary embolism) and all-cause death. Results: A total of 509 patients were prescribed rivaroxaban during the study period. The most common indication for rivaroxaban was non-valvular AF (65.3%) and VTE (34.7%). The mean age was 60.4 ± 16.4 years, and 50.8% were female. The median CHA2DS2-Vasc score was 2.1 in patients on rivaroxaban for non-valvular AF. Bleeding occurred in 72 (14.1%) patients, of which 20 (3.9%) had major bleeds. Thrombosis events occurred in 13 (2.5%) patients in the overall cohort. Fourteen (2.7%) patients died during the study, including a case of fatal bleeding secondary to rivaroxaban. Conclusion: This study describes the use of rivaroxaban in a broad patient population in clinical practice in the Middle East. The overall bleeding and thrombosis rates in this study were comparable to those seen in major clinical trials. [GMJ.2020;9:e1882] DOI:10.31661/gmj.v9i0.1882

11 February 2022 in Journal of Taibah University Medical Sciences
Verified
Journal Article
Open access
MBMuhammad I. Butt
Muhammad I. Butt
NANouf Alzuhayri
Nouf Alzuhayri
MRMuhammad Riazuddin
Muhammad Riazuddin
ABAbdulmohsen M.K. Bakhsh
Abdulmohsen M.K. Bakhsh
This study aimed to compare the current Kingdom-wide practice with our prior institutional study on use of the short synacthen test (SST), and to determine whether physician specialty or grade is associated with a tendency toward using a particular protocol. We surveyed clinicians registered with the Saudi Medical Council to determine the different SST protocols used within KSA. We received 162 responses, 66 (41%) from endocrinologists and the remainder from internists. A total of 61 (38%) respondents were consultants, whereas the rest were non-consultant grade. The clinicians indicated metabolic derangements, such as hypotension (78%), hyponatremia (65%), hypoglycemia (59%), and hyperkalemia (54%), as the main reasons for performing the test. Most clinicians used the SST protocol, which measures baseline serum cortisol (90%) and ACTH (78%) on the test day. A total of 75% of the physicians measured both the 30- and 60-minute serum cortisol after ACTH injection. Of these clinicians, 13% reported that the cortisol levels were below the pass threshold at 30 min but reached the pass threshold only at 60 min. The SST was normal 90% of the time when performed. A total of 93% of the clinicians considered a stimulated cortisol level of 550 nmol/L to be the threshold for normal adrenal function. The survey confirms that 60-min serum cortisol should be part of the SST protocol to avoid false-positive results. Moreover, clinicians should consider other causes of these metabolic derangements before requesting a SST, particularly in patients with a low pretest probability.